The FDA's top drug regulator indicated in her first address to staff that she will scrutinize antidepressants and shots used to protect babies from RSV ...

As smoking rates fall in the U.S., startups and influencers are pushing the purported cognitive and health benefits of ...

And there’s more news out of the FDA: The agency has installed an AI industry vet to steer digital health, and new CDER chief Tracy Beth Høeg tells staff she’s keen to revisit SSRIs in pregnancy and ...

The Texas AG has filed a lawsuit accusing Sanofi of providing kickbacks to doctors, in the form of a free network of nurses ...

A handful of states are considering initiatives to increase funding for scientific research as uncertainty around federal ...

Grail's blood test for detecting cancer early failed to meet its main goal in a giant study being conducted with England’s ...

After years of grand ambitions, the federal government disclosed that it is months away from rolling out a centralized list ...

Federal officials have missed the legal deadline to notify the public of an upcoming ACIP meeting, raising questions about ...

We do not let pilots fly without instrument support simply because they technically could. Why should medicine be different?” ...

The top drug regulator at the FDA told staff she plans to question the safety of taking SSRIs in pregnancy and of RSV shots ...

Bhattacharya is taking the role after the previous acting director, Health and Human Services Department Deputy Secretary Jim ...

Hims & Hers is buying the Australian telehealth firm Eucalyptus as it looks to make inroads in more countries globally.